CIK: 1290747 - Address: C/o Harpoon Therapeutics, Inc., 131 Oyster Point Boulevard, Suite 300, South San Francisco, CA 94080
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

9/6/19 19:17
6/5/19
HARPHarpoon Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcMahon Gerald PhdCADOP,CEOM.d1020.60000169999%172D
5/16/19 08:32
5/14/19
HARPHarpoon Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcMahon Gerald PhdCADOP,CEOP1010.1601503D
5/10/19 08:31
5/8/19
HARPHarpoon Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcMahon Gerald PhdCADOP,CEOP1110.56011002D
5/7/19 16:12
5/3/19
HARPHarpoon Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagMcMahon Gerald PhdCADOP,CEOP1110.5301New1D
6/10/11 16:49
6/9/11
PARDPoniard Pharmaceuticals, Inc.WAHealthDrugPharmaceutical PreparationsMcMahon Gerald PhdCADM.d00.0005427774D
12/31/08 13:03
12/30/08
PARDPoniard Pharmaceuticals, Inc.WAHealthDrugPharmaceutical PreparationsMcMahon Gerald PhdCADOCEOP101.29086220D
12/30/08 15:23
12/29/08
PARDPoniard Pharmaceuticals, Inc.WAHealthDrugPharmaceutical PreparationsMcMahon Gerald PhdCADOCEOP101.400715612D
3/7/08 15:42
3/6/08
PARDPoniard Pharmaceuticals, Inc.WAHealthDiagnIn Vitro & In Vivo DiagnosticMcMahon Gerald PhdCADOCEOP153.93044685D
5/26/04 09:37
5/25/04
NERXNeorx CorpWAHealthDiagnIn Vitro & In Vivo DiagnosticMcMahon Gerald PhdWAOCEOP142.7505New5D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact